Nuveen Asset Management, LLC Ampio Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $77,109 - $226,508	-481,934 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $36,641 - $111,887	-65,431 Reduced 11.95%	481,934 $280,000
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.8 $4,550 - $6,769	-3,761 Reduced 0.68%	547,365 $986,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $859,756 - $1.09 Million	551,126 New	551,126 $920,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.